Attached files
| file | filename |
|---|---|
| EX-99.1 - EXHIBIT 99.1 - MIMEDX GROUP, INC. | ex99_1.htm |
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act 1934
Date of Report (date of earliest event reported): July 15, 2013
MIMEDX GROUP, INC.
(Exact name of registrant as specified in charter)
|
Florida
|
000-52491
|
26-2792552
|
|
(State or other jurisdiction of incorporation)
|
(Commission File Number)
|
(IRS Employer Identification No.)
|
|
1775 West Oak Commons Ct.
|
30062
|
|
|
Marietta, GA
|
(Zip Code)
|
|
|
(Address of principal executive offices)
|
|
|
(770) 651-9100
(Registrant’s telephone number, including area code)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of registrant under any of the following provisions:
| o | Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
| o | Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
| o | Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
| o | Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
| Item 8.01 | Other Events |
On July 15, 2013, MiMedx Group, Inc., (“MiMedx” or the “Company”) issued a press release announcing that the Company will slightly exceed the $13.5 million high end of its previously communicated revenue range for second quarter of 2013.
The Company also increased its guidance for the lower end of its full year 2013 revenue range. MiMedx reported that it now expects the Company's 2013 full year revenue to be in the range of $54 million to $60 million. Where revenue falls within this range is dependent on the reimbursement approval of the three remaining Medicare Contractors.
A copy of the press release is attached hereto as Exhibit 99.1 and is incorporated by reference herein.
| Item 9.01 | Financial Statements and Exhibits |
| (c) | Exhibits |
|
Exhibit No.
|
|
Description
|
|
|
|
|
|
|
MiMedx Group, Inc. Press Release, dated July 15, 2013
|
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
|
|
MIMEDX GROUP, INC.
|
||
|
|
|
|
|
|
Dated: July 19, 2013
|
By:
|
/s/: Michael J. Senken
|
|
|
|
|
Michael J. Senken, Chief Financial Officer
|
|